市場調查報告書
商品編碼
1504161
填充劑製造的市場規模,佔有率,預測,趨勢分析:提供(包裝類型,設備,服務)製劑(口服,非口服)用途(生技藥品,低分子)各終端用戶-2031年前的世界預測Fill-finish Manufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Packaging Type Equipment, Service) Formulation (Oral, Parenteral) Application (Biologics, Small Molecule) End User - Global Forecast to 2031 |
預計到 2031 年,填充和飾面製造市場將達到 191.4 億美元,2024 年至 2031 年複合年增長率為 9.9%。
該報告在廣泛的二次和初級研究以及對填充和完成製造市場場景的深入分析後,對關鍵行業驅動因素、限制因素、課題和機會進行了分析。灌裝和完成製造市場的成長是由生物製藥行業的成長、製藥和生物製藥公司擴大產能的努力、灌裝和完成製造流程的進步以及對預充式註射器的需求不斷增長所推動的。然而,高昂的營運成本和在整個製造過程中保持藥物功效的課題可能會限制市場成長。
此外,旨在提高疫苗接種率、更加關註生物相似藥開發以及增加對新型生物製劑開發的投資的努力預計將為市場成長創造機會。然而,對灌裝生產的嚴格監管要求以及準確填充特定劑量所涉及的複雜性是限制市場成長的一些課題。
(註:提供前 5 名公司 SWOT 分析)
Fill-finish Manufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Packaging Type {Vial, Syringe, Cartridge} Equipment, Service) Formulation (Oral, Parenteral) Application (Biologics, Small Molecule) End User-Global Forecast to 2031
The Fill-finish Manufacturing Market is Projected to Reach $19.14 Billion by 2031, at a CAGR of 9.9% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the fill-finish manufacturing market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the fill-finish manufacturing market is driven by the growth of the biopharmaceutical industry, initiatives by pharmaceutical & biopharmaceutical companies to expand their production capacities, advancements in fill-finish manufacturing processes, and the increasing demand for pre-filled syringes. However, high operational costs and challenges in maintaining drug potency throughout the manufacturing process may restrain the market's growth.
Moreover, initiatives aimed at increasing vaccination rates, increasing focus on biosimilar development, and rising investments in the development of new biologics are expected to create market growth opportunities. However, stringent regulatory requirements governing fill-finish manufacturing and the complexities associated with accurately filling specific medication doses are some of the challenges impeding the market's growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2024). The key players operating in the fill-finish manufacturing market are Syntegon Technology GmbH (Germany), Becton, Dickinson and Company (U.S.), Industria Macchine Automatiche S.p.A. (Italy), West Pharmaceutical Services, Inc. (U.S.), Catalent, Inc. (U.S.), AbbVie Inc. (U.S.), Gerresheimer AG (Germany), AptarGroup, Inc. (U.S.), OPTIMA packaging group GmbH (Germany), Baxter International Inc. (U.S.), C.H. Boehringer Sohn AG & Co. KG (Germany), Schott Pharma AG & Co. KGaA (Germany), SGD Pharma (France), and Stevanato Group (Italy).
Among the offerings covered in this report, in 2024, the packaging type segment is expected to account for the largest share of the fill-finish manufacturing market. The packaging type segment is further sub-segmented into vials, syringes, cartridges, ampoules, and accessories. The large market share of this segment is attributed to the increasing approval for biologics, increasing demand for parenteral formulations, recurring demand for fill-finish packaging, and advancements in fill-finish technology. Additionally, there is an increasing demand for fill-finish services is increasing for vials, cartridges, and other packaging types to reduce product wastage and maintain sterility while filling the drug.
Among the formulations covered in this report, in 2024, the parenteral segment is expected to account for the largest share of the fill-finish manufacturing market. Vials, syringes, cartridges, and ampoules are commonly used for the packaging of parenteral drug formulations. The increasing demand for injectables, technological advancements in materials, and designs of pre-fillable syringes and vials are contributing to the large market share of this segment. Additionally, the increasing number of approvals for injectables is further contributing to the segment growth. For instance, in September 2023, Pfizer Inc. (U.S.) and BioNTech SE (Germany) obtained supplemental Biologics License Application approval from the U.S. FDA for their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine.
Among the sterilization processes covered in this report, in 2024, the aseptic processing segment is expected to account for the largest share of the fill-finish manufacturing market. The demand for aseptic processing is driven by the need to sterilize heat-sensitive drugs such as biologics, vaccines, and other parenteral medications. Moreover, there is a growing demand for aseptic processing for handling heat-sensitive drugs such as antibiotics, nasal sprays, ear drops, oral drops, and diabetes medications.
Among the applications covered in this report, the biologics segment is projected to register a higher CAGR during the forecast period. The segment's rapid growth can be attributed to the rising demand for biologics, expansion of biologics manufacturing facilities, rising approvals for biologic products, and product launches by key market players. For instance, in June 2023, UCB (Belgium), a biopharmaceutical company, received U.S. FDA approval for RYSTIGGO (rozanolixizumab-noli) under Priority Review designation for the treatment of generalized myasthenia gravis (gMG) in adult patients.
Among the end users covered in this report, in 2024, the CROs & CDMOs segment is expected to account for the largest share of the fill-finish manufacturing market. The surge in clinical trials and rapid growth in the healthcare and life sciences sectors are accelerating the outsourcing trend to ensure efficient and cost-effective drug filling. Additionally, strategic partnerships between pharmaceutical companies and CROs & CDMOs and stringent regulatory requirements governing fill-finish processes are contributing to the largest share of the segment.
An in-depth analysis of the geographical scenario of the global fill-finish manufacturing market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia-Pacific is projected to register the highest CAGR of over 11.3% during the forecast period. The growth of this regional market is driven by the growth of the pharmaceutical market, increasing investments in R&D by pharmaceutical & biopharmaceutical companies, and favorable regulatory policies. Additionally, China has become an attractive destination for international pharmaceutical companies seeking to streamline product timelines and minimize production costs.
Fill-finish Manufacturing Market Assessment-by Offering
Note: Other Materials include rubber, metal, and paper.
Other Packaging Instruments include powder sachet filling & packaging equipment, nested filling systems, tube filling equipment, and cream filling equipment.
Other Packaging Services include capsule filling, tube filling, sachet filling, and powder filling.
Fill-finish Manufacturing Market Assessment-by Formulation
Note: Other Formulations include nasal, ocular, intradermal, and transcutaneous (TC) formulations
Fill-finish Manufacturing Market Assessment-by Sterilization Process
Fill-finish Manufacturing Market Assessment-by Application
Fill-finish Manufacturing Market Assessment-by End User
Fill-finish Manufacturing Market Assessment-by Geography
(Note: SWOT Analyses of the Top 5 Companies Will Be Provided.)